Evidence-Based Complementary and Alternative Medicine / 2015 / Article / Tab 5

Research Article

Chinese Herbal Decoction Based on Syndrome Differentiation as Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer: An Exploratory and Small Prospective Cohort Study

Table 5

Function assessment in different phases.

AnalysisBaseline (I)Observed (II)Differences (I-II)
Mean95% CIMean95% CIMean95% CI

 First stage ()1.541.34 to 1.731.361.07 to 1.640.18−0.16to 0.530.29
 Second stage ()1.180.90 to 1.461.391.17 to 1.61−0.21−0.55 to 0.130.21
TCM syndromes
 First stage ()6.715.36 to to 6.111.530.70 to 2.370.001
 Second stage ()3.792.85 to 4.853.292.79 to 3.820.57−0.45 to 1.450.29

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.